Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Cancer free patients

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Aug 19, 2024 8:55pm

155 Views

Post# 36187042

RE:Cancer free patients

Good observation! I suggested a while back that one possible way to treat non responders o and recurring patients is to use both IV Rutherin and intravesicle Ruvidar in combination in those cases to treat deeper or harder to reach cancer cells. They would also be able to treat UTUC if they use Rutherin, via X-rays .

<< Previous

Bullboard Posts

Next >>

Sony’s Alpha 1 II: A new professional photography standard?